Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 15.3
(-1.48%)
CNY 15.3
(-1.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 665.28 Million CNY | 24.34% |
| 2022 | 460.5 Million CNY | -7.09% |
| 2021 | 409.02 Million CNY | 171.47% |
| 2020 | 171.04 Million CNY | -23.58% |
| 2019 | 250.71 Million CNY | 43.54% |
| 2018 | 178.11 Million CNY | 26.1% |
| 2017 | 147.9 Million CNY | 10.99% |
| 2016 | 135.27 Million CNY | 49.46% |
| 2015 | 92.85 Million CNY | 66.77% |
| 2014 | 54.6 Million CNY | 66.8% |
| 2013 | 32.95 Million CNY | 8.9% |
| 2012 | 30.37 Million CNY | -16.57% |
| 2011 | 36.6 Million CNY | 7.84% |
| 2010 | 33.44 Million CNY | 32.91% |
| 2009 | 26.66 Million CNY | 22.87% |
| 2008 | 18.98 Million CNY | 45.9% |
| 2007 | 13.72 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 109.58 Million CNY | -5.8% |
| 2024 Q2 | 116.33 Million CNY | -28.43% |
| 2024 Q1 | 153.56 Million CNY | 84.48% |
| 2023 Q2 | 183.2 Million CNY | 15.56% |
| 2023 Q3 | 192.24 Million CNY | 4.94% |
| 2023 Q4 | 63.25 Million CNY | -67.1% |
| 2023 FY | - CNY | 24.34% |
| 2023 Q1 | 158.53 Million CNY | 102.26% |
| 2022 Q3 | 178.73 Million CNY | 25.44% |
| 2022 FY | - CNY | -7.09% |
| 2022 Q4 | 78.37 Million CNY | -56.15% |
| 2022 Q2 | 142.48 Million CNY | 81.62% |
| 2022 Q1 | 78.45 Million CNY | -77.73% |
| 2021 FY | - CNY | 171.47% |
| 2021 Q3 | 47.35 Million CNY | 22.71% |
| 2021 Q1 | 71.04 Million CNY | 80.23% |
| 2021 Q2 | 38.58 Million CNY | -45.69% |
| 2021 Q4 | 352.31 Million CNY | 644.02% |
| 2020 Q4 | 39.42 Million CNY | -9.5% |
| 2020 FY | - CNY | -23.58% |
| 2020 Q3 | 43.55 Million CNY | 17.9% |
| 2020 Q2 | 36.94 Million CNY | -11.4% |
| 2020 Q1 | 41.69 Million CNY | -28.51% |
| 2019 Q4 | 58.32 Million CNY | -20.33% |
| 2019 FY | - CNY | 43.54% |
| 2019 Q1 | 45.57 Million CNY | 45.54% |
| 2019 Q2 | 60.05 Million CNY | 31.76% |
| 2019 Q3 | 73.2 Million CNY | 21.9% |
| 2018 Q2 | 44.54 Million CNY | 8.47% |
| 2018 Q1 | 41.06 Million CNY | 112.56% |
| 2018 FY | - CNY | 26.1% |
| 2018 Q4 | 31.31 Million CNY | -30.13% |
| 2018 Q3 | 44.82 Million CNY | 0.62% |
| 2017 FY | - CNY | 10.99% |
| 2017 Q4 | 19.31 Million CNY | -38.13% |
| 2017 Q3 | 31.22 Million CNY | -9.4% |
| 2017 Q2 | 34.46 Million CNY | 14.92% |
| 2017 Q1 | 29.99 Million CNY | 23.44% |
| 2016 Q4 | 24.29 Million CNY | -5.95% |
| 2016 FY | - CNY | 49.46% |
| 2016 Q1 | 28.06 Million CNY | 27.4% |
| 2016 Q2 | 28.91 Million CNY | 3.06% |
| 2016 Q3 | 25.83 Million CNY | -10.67% |
| 2015 Q3 | 15.68 Million CNY | 0.11% |
| 2015 FY | - CNY | 66.77% |
| 2015 Q1 | 15.87 Million CNY | 95.05% |
| 2015 Q2 | 15.67 Million CNY | -1.26% |
| 2015 Q4 | 22.02 Million CNY | 40.4% |
| 2014 Q1 | 7.13 Million CNY | 84.91% |
| 2014 FY | - CNY | 66.8% |
| 2014 Q4 | 8.13 Million CNY | -29.38% |
| 2014 Q3 | 11.52 Million CNY | 20.59% |
| 2014 Q2 | 9.55 Million CNY | 33.96% |
| 2013 Q4 | 3.85 Million CNY | -5.3% |
| 2013 Q2 | 6.85 Million CNY | -6.98% |
| 2013 Q3 | 4.07 Million CNY | -40.61% |
| 2013 Q1 | 7.37 Million CNY | 2.3% |
| 2013 FY | - CNY | 8.9% |
| 2012 Q4 | 7.2 Million CNY | 199.65% |
| 2012 Q1 | 5.35 Million CNY | -43.17% |
| 2012 FY | - CNY | -16.57% |
| 2012 Q2 | 8.7 Million CNY | 62.52% |
| 2012 Q3 | 2.4 Million CNY | -72.38% |
| 2011 Q1 | 7.05 Million CNY | -19.53% |
| 2011 Q3 | 6.39 Million CNY | -34.14% |
| 2011 FY | - CNY | 7.84% |
| 2011 Q4 | 9.42 Million CNY | 47.56% |
| 2011 Q2 | 9.7 Million CNY | 37.48% |
| 2010 Q1 | 8.78 Million CNY | 75.36% |
| 2010 Q2 | 8.9 Million CNY | 1.31% |
| 2010 FY | - CNY | 32.91% |
| 2010 Q4 | 8.77 Million CNY | 152.79% |
| 2010 Q3 | 3.46 Million CNY | -61.03% |
| 2009 Q3 | 6.25 Million CNY | 0.0% |
| 2009 Q4 | 5.01 Million CNY | -19.86% |
| 2009 FY | - CNY | 22.87% |
| 2008 FY | - CNY | 45.9% |
| 2007 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.14 Billion CNY | 41.724% |
| Zhejiang Zhenyuan Share Co., Ltd. | 220.46 Million CNY | -201.771% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -83.34 Million CNY | 898.259% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -2.67 Million CNY | 25001.108% |
| Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 237.592% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | -905.719% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 4.85 Billion CNY | 86.305% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | -471.093% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | -70.11% |